Clinical Trial Update: Safety, Tolerability and Pharmacokinetic Characteristics Evaluation of DA-302168S Tablets [Phase 1]

View source ↗

Summary

This completed Phase 1 trial evaluates safety, tolerability, and pharmacokinetic characteristics of DA-302168S tablets in individuals with overweight or obesity…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• DA-302168S

Snippet

Sponsor: Chendu DIAO Pharmaceutical Group CO., LTD. | Conditions: Overweight and Obesity | Phase 1 | Status: COMPLETED